Healthcare and Life Sciences

Format: 2017-01-20
Format: 2017-01-20
December 14, 2016 | 85 Pages | SKU: IRTNTR11134

Overview of the global artificial pancreas devices system market

Market research analysts at Technavio predict that the global artificial pancreas devices system market will grow steadily during the next four years and post an impressive revenue of over USD 1 billion by 2020. The market has witnessed a rapid increase in technological integration, which according to this market research analysis will be one of the primary growth factors for this market. The need for artificial pancreas devices systems to mimic the function of a healthy pancreas will induce vendors to focus on the adoption of advanced technologies. Vendors have already started integrating their artificial pancreas devices systems (APDS) with several sensors, software, and related algorithms to ensure the effective functioning of APDS. For instance, Medtronic has integrated their MiniMed 530G system with SmartGuard Technology, which helps in effectively controlling glucose levels. Additionally, the device is also integrated with the Enlite sensor, which enables the device to monitor glucose levels and take readings at regular intervals and also provide alerts during fluctuations. Such advancements will enable companies to introduce effective artificial pancreas systems,  which, in turn, will boost their demand among end-users.

One of the major trends that will gain traction in this market is the increasing demand for remote monitoring applications. The growing need for home healthcare monitoring will drive the need for remote patient monitoring systems in the APDS market as well. This will induce vendors to develop an

December 13, 2016 | 76 Pages | SKU: IRTNTR11109

Overview of the global laparotomy sponges market

The global laparotomy sponges market is anticipated to grow at a steady rate and will post a CAGR of close to 8% during the forecast period.  Growing advancements in technology to perform abdominal laparotomy procedures will drive the growth prospects for the global laparotomy sponges market until the end of 2020. These technological advancements will allow both vendors and the healthcare providers to address healthcare challenges such as sterilization and access to affordable healthcare services, which results in the development of efficient products. For instance, the laparotomy sponges labeled with RFID tags helps reduce the retention of sponges and improve the quality of the operation. In addition, the market analysis also shows that products such as sterile laparotomy sponge ensure enhanced safety from infective agents. For instance, Medical Action Industries developed X-ray detectable laparotomy sponges that have a high quality and reliability by incorporating advanced and modern systems to provide sterile laparotomy sponges. Similarly, Stryker recently introduced the SurgiCount sponge system, which helps to avoid the retainment of surgical sponges in the body.

The growing focus on developing economies will drive the growth prospects for the global laparotomy sponges market for the next four years. One of the major factors contributing to market opportunities for these vendors in emerging economies such as India, China, Africa, and the Middle East is the presence of a huge customer base and high demand. Also, the growing demand for lap sponges fosters its growth prospects across the medical devices and textile industry.

Competitive landscape and key vendors

The global laparotomy sponges market is highly fragmented and

December 13, 2016 | 80 Pages | SKU: IRTNTR11106

Overview of the global HPV testing market

The global human papillomavirus (HPV) testing market is anticipated to grow rapidly and will post a CAGR of more than 16% during the forecast period. The increasing trend of early detection to prevent the growing prevalence of cervical cancer will drive the growth prospects for the global HPV testing market until the end of 2020. The increasing adoption of HPV tests among women will enable the early detection of high-risk HPV genotypes such as HPV 16, 18, 31, 33, 45, and others. Also, since the government has released guidelines in various countries recommending women aged 26-65 years to undergo HPV testing for the early detection of cervical cancer, the adoption of HPV testing is increasing. Some of the countries who have benefitted from early detection due to government regulations include regions such as Americas, EMEA, and APAC. Since the Affordable Care Act in the US has increased the adoption of HPV testing, around 75% of women have undergone early diagnosis. Similarly, the government initiatives in Germany to invite women aged between 20 and 60 in 2018 will drive the adoption rate of the testing kit. Furthermore, the changes made in National Cervical Screening Program of 2016 in New Zealand, APAC, to include women aged between 20 to 25 years will boost awareness about cervical cancer among women.

In terms of geography, the Americas accounted for the maximum market share during 2015 and will continue to dominate the market for the next few years. One of the major factors responsible for the market’s growth in North America is the growing number of cervical cancer patients, which accounts for more than 13,000 cases each year. Also, the government initiatives in various countries such as the US, Canada, and Brazil, the awareness and adoption of

December 13, 2016 | 65 Pages | SKU: IRTNTR11105

Overview of the global Pompe disease treatment market

Market research analysts at Technavio predict that the global Pompe disease treatment market will grow steadily during the next four years and post a CAGR of almost 12% by 2020. This market research analysis identifies the availability of reimbursement policies for the treatment Pompe disease as one of the primary factors that will have a positive impact on the growth of this market. It has been observed that the treatment of Pompe disease costs around USD 100,000 to USD 300,000 for an individual every year, making it difficult for individuals to continue with the treatment for a long period. However, financial support from various organizations such as the Canadian Association of Pompe, Acid Maltase Deficiency Association, and International Pompe Association enables patients continue their treatment, which will drive the growth of the market. Additionally, initiatives from the governments of countries such as Sweden, the Netherlands, and South Korea that focus on approving guidelines for the reimbursement of individuals undergoing enzyme replacement therapy (ERT) will also bolster the growth of the market in the next four years.

One of the major trends that will gain traction in the Pompe treatment market is the emergence of immunotherapy for Pompe disease. Immunotherapy enhances the powers of the immune system and aids in fighting various respiratory, infectious, and autoimmune disorders. Advances in preventing Immunoglobin (IgG) production have shown a significant effect in both pre-clinical and clinical studies. This will result in the increased adoption of drugs such as mycophenolate mofetil, cyclophosphamide, and methotrexate for the prevention of responses to ERT as they have

December 12, 2016 | 103 Pages | SKU: IRTNTR11086

Overview of the global hypodermic needles market

Technavio’s market research analyst predicts the global hypodermic needles market to grow at a CAGR of almost 7% between 2016 and 2020.  Several governments across the world have started adopting legislation that restricts the frequency of needlestick injuries (NSIs). With the enforcement of these legislations, the healthcare and pharmaceutical markets worldwide are now shifting towards the mandatory use of safety needles and syringes to help protect those at a risk of infection from NSIs and other unsafe injection practices. Legislation has mandated employers within the industry to implement formal written exposure control plans and actively involve frontline HCWs, while choosing safe needle devices. The regulations also require employers to create and maintain sharps injury logs comprising detailed information on the type, brand, and manufacturer of devices associated with such injuries. Such compulsory regulations will hugely impact the global market for hypodermic needles and will increase its market size in the coming years.

In terms of geography, the Americas dominated the market in 2015 and was the largest revenue contributing region during the same period.  Much of the region’s growth can be attributed to the high sales of high-priced passive safety hypodermic needles in the large and mid-tier hospitals. With a well-established healthcare infrastructure and surging awareness among individuals about blood-borne diseases, the Americas is witnessing strong sales of automatic retracting hypodermic needles. Also, several healthcare facilities are completely replacing the standard safety hypodermic needles by the semi-automatic and automatic retractable safety hypodermic needles, which will further contribute to the growth of the market in this

December 12, 2016 | 129 Pages | SKU: IRTNTR11089

Global outlook of the robotic surgery market

Technavio’s market research analysts predict the global robotic surgery market to grow steadily during the forecast period and post a CAGR of more than 11% by 2020. This industry research report identifies the increased focus of surgeons towards minimally invasive surgeries to be one of the major factors that will have a positive impact on the growth of the surgical robotics market in the coming years. Benefits such as reduced recovery time, hospital stay, and postoperative pain have resulted in the increasing preference for minimally invasive surgeries by both surgeons and patients. Since the use of robotics gives a better view of the target area than conventional techniques and allow precise movement of instruments, the coming years will witness an increased adoption of robotic-assisted techniques, which will consequently drive the growth of the robotic surgery market.

This industry research report estimates that in terms of geographical regions, the Americas will be the major revenue contributor to the market throughout the next four years. Increasing incidences of chronic disorders and the advantages of robotic surgeries over the other traditional methods such as laparoscopy and open surgeries will bolster the market’s growth prospects in this region.

Competitive landscape and key vendors

Characterized by the presence of major Tier 1 and Tier 2 companies and several small companies, the market appears to be fragmented and is highly competitive. Technological advancements and new product launches will increase the level of competition in the already competitive market. To improve product quality and product development, Tier 1 and Tier 2